2-(4'-(ethylsulfonyl)-2'-methyl-5-(trifluoromethyl)biphenyl-2-yloxy)acetic acid

ID: ALA1778639

PubChem CID: 53359023

Max Phase: Preclinical

Molecular Formula: C18H17F3O5S

Molecular Weight: 402.39

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCS(=O)(=O)c1ccc(-c2cc(C(F)(F)F)ccc2OCC(=O)O)c(C)c1

Standard InChI:  InChI=1S/C18H17F3O5S/c1-3-27(24,25)13-5-6-14(11(2)8-13)15-9-12(18(19,20)21)4-7-16(15)26-10-17(22)23/h4-9H,3,10H2,1-2H3,(H,22,23)

Standard InChI Key:  KDOSMMYSHYZFQE-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 28  0  0  0  0  0  0  0  0999 V2000
   -0.8750  -11.3917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4583  -12.1083    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0460  -11.3892    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7306  -13.7750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7318  -14.6023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0169  -15.0152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3005  -14.6019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3034  -13.7713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0187  -13.3622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5904  -13.3561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8772  -13.7690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1648  -13.3545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1674  -12.5286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8885  -12.1190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5979  -12.5358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0212  -12.5372    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3080  -12.1226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3104  -11.2976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5972  -10.8829    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0261  -10.8872    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0171  -15.8402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3028  -16.2529    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7317  -16.2525    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0250  -16.6625    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.2615  -12.5213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9748  -12.1069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8763  -14.5940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 13 14  1  0
  7  8  1  0
 14 15  2  0
 15 10  1  0
  4  5  2  0
  9 16  1  0
  8  9  2  0
 16 17  1  0
  9  4  1  0
 17 18  1  0
  3  2  2  0
 18 19  1  0
  8 10  1  0
 18 20  2  0
  5  6  1  0
  6 21  1  0
 10 11  2  0
 21 22  1  0
 21 23  1  0
 11 12  1  0
 21 24  1  0
 13  2  1  0
  6  7  2  0
  2 25  1  0
 12 13  2  0
 25 26  1  0
  2  1  2  0
 11 27  1  0
M  END

Associated Targets(Human)

Plasma (7708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGDR2 Tchem G protein-coupled receptor 44 (4688 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsomes (16955 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasma (328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (810 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CRTH2 Chemoattractant receptor-homologous molecule expressed on Th2 cells (44 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ptgdr2 G protein-coupled receptor 44 (29 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ptgdr2 G protein-coupled receptor 44 (45 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hepatocyte (2621 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 402.39Molecular Weight (Monoisotopic): 402.0749AlogP: 3.94#Rotatable Bonds: 6
Polar Surface Area: 80.67Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 3.57CX Basic pKa: CX LogP: 3.68CX LogD: 0.33
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.79Np Likeness Score: -1.29

References

1. Luker T, Bonnert R, Schmidt J, Sargent C, Paine SW, Thom S, Pairaudeau G, Patel A, Mohammed R, Akam E, Dougall I, Davis AM, Abbott P, Brough S, Millichip I, McInally T..  (2011)  Switching between agonists and antagonists at CRTh2 in a series of highly potent and selective biaryl phenoxyacetic acids.,  21  (12): [PMID:21592791] [10.1016/j.bmcl.2011.04.101]
2. Mark Wenlock and Nicholas Tomkinson. Experimental in vitro DMPK and physicochemical data on a set of publicly disclosed compounds,  [10.6019/CHEMBL3301361]